U.S. Software Stock News

Stratasys Ltd. ( NASDAQ:SSYS ) shareholders would be excited to see that the share price has had a great month, posting...

While ICU Medical, Inc. ( NASDAQ:ICUI ) might not have the largest market cap around , it saw a significant share price...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

We'd be surprised if Orthofix Medical Inc. ( NASDAQ:OFIX ) shareholders haven't noticed that the President, Massimo...

It is hard to get excited after looking at MGE Energy's (NASDAQ:MGEE) recent performance, when its stock has declined...

Unfortunately for some shareholders, the LivePerson, Inc. ( NASDAQ:LPSN ) share price has dived 31% in the last thirty...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 20x, you may...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...

Key Insights Significantly high institutional ownership implies American Vanguard's stock price is sensitive to their...

Great Lakes Dredge & Dock Corporation ( NASDAQ:GLDD ), is not the largest company out there, but it received a lot of...

In early January 2026, Upstream Bio, Inc. presented at the 44th Annual J.P. Morgan Healthcare Conference, while analysts initiated and upgraded coverage around its asthma candidate verekitug and the upcoming Phase 2 VALINAT readout. The combination of growing physician enthusiasm for long-acting TSLP inhibition and expectations for the VALINAT data has sharpened investor focus on Upstream Bio’s clinical pipeline. Against this backdrop, we’ll examine how physician interest in verekitug and...

What the new Employee File Cabinet launch means for BBSI shareholders Barrett Business Services (BBSI) has rolled out its Employee File Cabinet HRIS module within the BBSI Client Portal, built with Box, giving clients a secure, centralized hub for key HR documents. The launch highlights BBSI’s ongoing push to consolidate HR workflows into a single portal experience. The company points to potential benefits around compliance, time savings, and employee access to their own documents. See our...

Calavo Growers (CVGW) just wrapped up FY 2025 with Q4 revenue of US$124.7 million and basic EPS of US$0.21. Trailing 12 month revenue came in at US$648.4 million and EPS at US$1.11, supported by a trailing net profit margin of 3.1% versus 1.0% in the prior year. Over the last few quarters, revenue has ranged from US$154.4 million to US$190.5 million with quarterly EPS between US$0.21 and US$0.38. This points to a picture of improving profitability that puts margins, rather than top line...

If you are wondering whether Douglas Emmett is priced attractively today, or if the share price still does not reflect its underlying real estate assets, this article explains what the current market value might be telling you. The stock recently closed at US$10.97, with returns of a 1.6% decline over 7 days, a 4.8% decline over 30 days, a 0.9% decline year to date, a 32.8% decline over 1 year and a 51.5% decline over 5 years. This performance may have changed how investors view its risk and...

Goldman Sachs FY 2025 Earnings Snapshot Goldman Sachs (GS) closed out FY 2025 with fourth quarter revenue of US$15.6 billion and basic EPS of US$14.27 on net income of US$4.4 billion, setting the tone for how investors are reading the latest numbers. Over the past six reported quarters, the bank has seen quarterly revenue move from US$12.3 billion in Q3 2024 to US$13.5 billion in Q4 2024 and then to US$15.6 billion in Q4 2025, while basic EPS shifted from US$8.52 to US$12.14 to US$14.27 over...

Mereo BioPharma Group recently reported that its Phase 3 Orbit and Cosmic trials of setrusumab in osteogenesis imperfecta missed their primary fracture reduction endpoints but achieved strong statistical improvements in bone mineral density, while also updating investors that its approximately US$41,000,000 cash balance at 31 December 2025 is expected to fund operations to mid-2027. Alongside reassessing the future of setrusumab with partner Ultragenyx, Mereo is pushing ahead with a single...

Apogee Enterprises, Inc.'s ( NASDAQ:APOG ) earnings announcement last week didn't impress shareholders. However, our...

Shareholders in Applied Digital Corporation ( NASDAQ:APLD ) may be thrilled to learn that the analysts have just...

Recently, TD Cowen and UBS both upgraded Enhabit to Buy, signaling a shift in analyst opinion on the home health and hospice provider. This cluster of upgrades suggests large institutions are reassessing Enhabit’s risk‑reward profile in light of its evolving operating backdrop. Next, we’ll examine how this renewed analyst confidence might influence Enhabit’s investment narrative, particularly around reimbursement resilience and growth. AI is about to change healthcare. These 30 stocks are...

As the United States stock market experiences a resurgence, with major indices like the Nasdaq, Dow Jones Industrial Average, and S&P 500 climbing on strong tech earnings and easing geopolitical tensions, investors are increasingly focused on identifying opportunities that may be undervalued. In this environment of fluctuating oil prices and robust tech performance, discerning stocks that are priced below their estimated value can offer potential advantages for those looking to capitalize on...

As the U.S. stock market experiences a surge, driven by strong performances in the tech sector and easing geopolitical tensions, investors are keenly observing growth companies that insiders are backing with significant ownership stakes. In this environment of rising indices and fluctuating oil prices, stocks with high insider ownership can offer an added layer of confidence for investors seeking to align with those who have intimate knowledge of their company's potential.

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Daktronics, Inc.'s ( NASDAQ:DAKT ) price-to-sales (or "P/S") ratio of 1.4x might make it look like a buy right now...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...